Atlas Trials

Effect of Evolocumab on Vascular Function

Clinical trial NCT03626831 · COMPLETED

Trial details

NCT number
NCT03626831
Sponsor
University of Erlangen-Nürnberg Medical School
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2019-04-04
Primary completion
2021-04-15
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.